The Role of the Osteoblast in Mediating Glucocorticoid-Induced Metabolic Dysfunction

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/632819

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Glucocorticoids (GC) exceed most other drugs in terms of numbers of patients treated and indications. Preventing or attenuating the deleterious effects of GC on fuel metabolism is therefore of great clinical significance. Our studies will create new knowledge regarding the mechanisms of GC-induced diabetes and osteoporosis, and will contribute to the development of new approaches that are essential to tackle the pressing medical problem of GC-induced disease.

Funded Activity Details

Start Date: 01-01-2010

End Date: 01-01-2014

Funding Scheme: NHMRC Project Grants

Funding Amount: $825,254.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Endocrinology

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Adverse effects | Glucocorticod-induced diabetes | Glucocorticod-induced obesity | Glucocorticod-induced osteoporosis | Glucocorticoids | Hyperglycaemia | Metabolic dysfunction | Osteoblast | Osteoporosis | Treatment and prevention

Related Links